CDTX: Cidara Therapeutics, Inc. Stock

by  •  • Comments Off on CDTX: Cidara Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 245.06
Enterprise Value ($M) 55.24
Book Value ($M) 163.31
Book Value / Share 14.92
Price / Book 1.50
NCAV ($M) 159.25
NCAV / Share 14.55
Price / NCAV 1.54

Profitability (mra)
Return on Invested Capital (ROIC) -1.02
Return on Assets (ROA) -2.53
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.25
Current Ratio 4.25

Balance Sheet (mrq) ($M)
Current Assets 210.74
Assets 214.80
Liabilities 51.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.27
Operating Income -91.22
Net Income -169.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -176.53
Cash from Investing -0.13
Cash from Financing 337.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Biotechnology Value Fund L P 9.99 55.52
12-09 13G Vivo Opportunity Fund Holdings, L.P. 5.50
12-04 13G Venrock Healthcare Capital Partners III, L.P. 9.99
12-03 13G TCG Crossover GP II, LLC 9.20
11-26 13D/A Ra Capital Management, L.p. 9.99 55.43
07-29 13G Canaan XII L.P. 9.99
07-29 13G BCLS Fund III Investments, LP 9.99
2024-02-14 13G/A Point72 Asset Management, L.P. 1.40 -67.68
2024-02-14 13G/A Nantahala Capital Management, LLC 1.70 -64.58

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 19,357 121,726 15.90
2025-03-10 9,993 98,643 10.13
2025-03-07 6,398 48,787 13.11
2025-03-06 6,591 48,963 13.46

(click for more detail)

Similar Companies
CARA – Cara Therapeutics, Inc. CASI – CASI Pharmaceuticals, Inc.
CDIO – Cardio Diagnostics Holdings, Inc. CDXC – ChromaDex Corporation
CELU – Celularity Inc.


Financial data and stock pages provided by
Fintel.io